Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behçet syndrome and non-infectious uveitis refractory to conventional therapy: a prospective, 6-month follow-up investigation

被引:0
作者
Cem Evereklioglu
Hatice Kubra Sonmez
Duygu Gulmez Sevim
Hatice Arda
Hidayet Sener
Osman Ahmet Polat
Fatih Horozoglu
机构
[1] Erciyes University Medical Faculty,Division of Uvea
来源
International Ophthalmology | 2023年 / 43卷
关键词
Adalimumab; Behçet disease; HLA-B27; Recurrent iridocyclitis; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4461 / 4472
页数:11
相关论文
共 83 条
  • [11] Nussenblatt RB(2014)Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients Rheumatology (Oxford) 53 2223-943
  • [12] Rosenbaum JT(2016)Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients N Engl J Med 375 932-1678
  • [13] Nussenblatt RB(2018)Adalimumab in patients with active noninfectious uveitis Br J Ophthalmol 102 1672-1011
  • [14] Palestine AG(2018)Adalimumab for the treatment of refractory active and inactive non-infectious uveitis Ann Rheum Dis 77 1003-189
  • [15] Chan CC(2017)ADJUVITE Study Group. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis Clin Rheumatol 36 183-1451
  • [16] Roberge F(2018)Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study Ophthalmology 125 1444-718
  • [17] Evereklioglu C(2019)Successful optimization of adalimumab therapy in refractory uveitis due to Behçet's disease J Ophthalmic Inflamm Infect 9 14-undefined
  • [18] Atienza-Mateo B(2020)Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet's disease-related uveitis Inflammopharmacology 28 711-undefined
  • [19] Martín-Varillas JL(2021)Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndrome Int Immunopharmacol 93 107430-undefined
  • [20] Calvo-Río V(undefined)Comparative study of adalimumab versus conventional therapy in sight-threatening refractory Behçet's uveitis with vasculitis undefined undefined undefined-undefined